TLS Advisors LLC
- SEC CIK
- 0001768824
- Latest filing
- Aug 14, 2026
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only.
- Positions
- 21
- No filing for Q3 2022
- Portfolio value
- $20.3M
- No filing for Q3 2022
TLS Advisors LLC did not file a 13F for Q3 2022, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Kludein I Acquisition Corp49878L117 | *W EXP 07/08/202 | 10,000 | $1.00K | <0.1% | – | – | – |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 22,000 | $51.0K | 0.3% | – | – | History |
| APTOAptose Biosciences Inc. | COM NEW | 89,403 | $52.0K | 0.3% | – | – | History |
| RRCRange Resources Corp | COM | 59,823 | $150.0K | 0.7% | – | – | History |
| NKTXNkarta, Inc. | COM | 26,842 | $161.0K | 0.8% | – | – | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 250 | $180.0K | 0.9% | – | – | History |
| Affimed N VN01045108 | COM | 161,971 | $201.0K | 1.0% | – | – | – |
| iShares Inc46434G780 | MSCI SINGPOR ETF | 13,600 | $255.0K | 1.3% | – | – | – |
| HOVHovnanian Enterprises Inc | CL A NEW | 6,472 | $272.0K | 1.3% | – | – | History |
| NBISNebius Group N.V. | Stock | 17,811 | $337.0K | 1.7% | – | – | History |
| FSTXF-star Therapeutics, Inc. | COM | 54,298 | $343.0K | 1.7% | – | – | History |
| LITSLite Strategy, Inc. | COM NEW | 2,010,285 | $490.0K | 2.4% | – | – | History |
| TSLATesla, Inc. | Stock | 6,000 | $739.0K | 3.6% | – | – | History |
| Bellus Health Inc New07987C204 | COM NEW | 125,731 | $1.03M | 5.1% | – | – | – |
| XENEXenon Pharmaceuticals Inc. | COM | 33,756 | $1.33M | 6.6% | – | – | History |
| SICPSilvergate Capital Corp | CL A | 79,795 | $1.39M | 6.8% | – | – | History |
| OABIOmniAb, Inc. | COM | 386,592 | $1.39M | 6.9% | – | – | History |
| METAMeta Platforms, Inc. | Stock | 14,589 | $1.76M | 8.7% | – | – | History |
| XOMAXOMA Royalty Corp | COM NEW | 124,024 | $2.28M | 11.2% | – | – | History |
| OVIDOvid Therapeutics Inc. | COM | 1,490,534 | $2.77M | 13.7% | – | – | History |
| EQTEQT Corp | Stock | 150,800 | $5.10M | 25.1% | – | – | History |